Novo Nordisk covers its dividend, and Pfizer doesn't, but investors appear increasingly worried about Novo's future.

Cameco's stock has fallen from $134 to $85, but that drop could be an opportunity for investors looking to invest in nuclear ...

Over his career, Warren Buffett established himself as one of the world's best investors. However, after 60 years at ...

At its current pace, the software giant could spend it all before 2030. What might that do to earnings per share?

And this spring, Lilly won regulatory approval for Foundayo. All three are part of a class of drugs known as GLP-1. These ...

Zepbound was a breakthrough. It became the first medicine to mimic the GLP-1 and GIP gut hormones and be approved for weight ...

Since 1945, the U.S. stock market has endured 37 corrections (declines of 10% or more), according to data from MUFG. These 10 ...

In its 2026 second-quarter earnings report, it also announced it was boosting its 2026 forecasts for revenue, adjusted EBITDA ...

Beyond defense, BWXT draws on decades of expertise in nuclear components and is well-positioned to capitalize on surging ...

Peter Thiel has scored some big wins as a tech investor and company founder, but that doesn't mean everything he touches will ...

With a forward price-to-earnings (P/E) ratio of 6.5 times fiscal 2027 analyst estimates, Micron's stock looks dirt cheap. The ...

The more important figure is the running total. Through three quarters, Tesla has delivered 1,324,681 vehicles, around 9% ...